Globavir Biosciences' Incubator/Accelerator Round

Globavir Biosciences raised a round of funding on November 13, 2014. Investors include StartX.

Globavir is a specialty biotechnology company with a unique approach to unlocking the potential of the 505(b)(2) regulatory path. Globavir leverages its highly predictive, machine learning GDDP platfo…

Articles about Globavir Biosciences' Incubator/Accelerator Round: